"Glox to develop precision antibiotics for cystic fibrosis" was originally created and published by Pharmaceutical Technology ...

K grant to accelerate development of Glox Therapeutics' novel precision antibiotics targeting AMR lung infections in people ...

Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM), Montréal, Québec H2X 0A9, Canada ...

Cystic fibrosis causes thickened mucus to form in the lungs and other organs, leading to severe breathing problems. It is a genetic disorder that can pass to children when both biological parents ...

Scientists at Caltech and Princeton University have discovered that bacterial cells growing in a solution of polymers, such ...

Cystic fibrosis is a genetic condition that causes mucus in the body to become thick and sticky. The mucus throughout the body is typically slippery and acts as a protective barrier in the lungs ...

The commitment of organizations like the Cystic Fibrosis Foundation to global research funding and access initiatives has further propelled market growth. Additionally, major pharmaceutical companies, ...

and mucus. Although most people without CF have two working copies of the CFTR gene, only one is needed to prevent cystic fibrosis. CF develops when neither gene works normally and therefore has ...

Experiments and modeling reveal the unexpected structure that can be seen in bacteria grown in mucus samples and biofilms.